The British Journal of Psychiatry (2010) 196: 89-91. doi: 10.1192/bjp.bp.109.070540
© 2010 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Poyurovsky, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poyurovsky, M.

EDITORIAL

Acute antipsychotic-induced akathisia revisited

Michael Poyurovsky

Tirat Carmel Mental Health Center, POB 9, Tirat Carmel 30200, Israel. Email: poyurovs{at}tx.technion.ac.il

Declaration of interest

M.P. is a member of the advisory board of Schering Plough, and served as a consultant for akathisia studies for Acadia Pharmaceuticals.

Akathisia remains one of the most prevalent and distressful antipsychotic-induced adverse events. Effective and well-tolerated treatment is a major unmet need in akathisia that merits a search for new remedies. Accumulating evidence indicates that agents with marked serotonin-2A receptor antagonism may represent a new class of potential anti-akathisia treatment.


Related articles in BJP:

The Myth of the Chemical Cure. A Critique of Psychiatric Drug Treatment
David Taylor
BJP 2010 196: 164-165. [Full Text]  



eLetters:

Read all eLetters

Acute antipsychotic-induced akathisia
Jonathan Lyons, et al.
BJP Online, 26 Feb 2010 [Full text]